Drugs / Leuveris
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01016210 | Feb 2010 → Mar 2012 | — | The Baruch Padeh Medical Center, Poriya | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Leuveris | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01016210 ↗ |
| Modality | Protein / enzyme biologic | “recombinant LH (rLH) supplementation (Leuveris)” NCT01016210 ↗ |